Intuitive Surgical, Inc. Third Quarter Earnings Sneak Peek

S&P 500 (NYSE:SPY) component Intuitive Surgical, Inc. (NASDAQ:ISRG) will unveil its latest earnings on Tuesday, October 18, 2011. Intuitive Surgical designs and manufactures da Vinci Surgical Systems, EndoWrist instruments and other surgical accessories.

Intuitive Surgical, Inc. Earnings Preview Cheat Sheet

Wall St. Earnings Expectations: The average estimate of analysts is for net income of $2.76 per share, a rise of 29% from the company’s actual earnings for the same quarter a year ago. During the past three months, the average estimate has moved up from $2.71. Between one and three months ago, the average estimate moved up. It has been unchanged at $2.76 during the last month. For the year, analysts are projecting profit of $11.48 per share, a rise of 21.2% from last year.

Past Earnings Performance: The company has beaten estimates the last four quarters and is coming off a quarter where it topped forecasts by 20 cents, reporting net income of $2.91 per share against a mean estimate of profit of $2.71 per share.

Investing Insights: has a Stock Chart Technical Analysts Dream About.

Wall St. Revenue Expectations: Analysts are projecting a rise of 21.3% in revenue from the year-earlier quarter to $417.8 million.

Analyst Ratings: Analysts seem relatively indifferent about Intuitive Surgical with nine of 14 analysts surveyed maintaining a hold rating.

A Look Back: In the second quarter, profit rose 32.4% to $117.4 million ($2.91 a share) from $88.7 million ($2.19 a share) the year earlier, exceeding analyst expectations. Revenue rose 21.4% to $425.7 million from $350.7 million.

Key Stats:

The company has enjoyed double-digit year-over-year percentage revenue growth for the past four quarters. Over that span, the company has averaged growth of 20.7%, with the biggest boost coming in the third quarter of the last fiscal year when revenue rose 22.9% from the year earlier quarter.

The company has seen net income rise in three straight quarters. Net income rose 22% in the first quarter and 56.3% in the fourth quarter of the last fiscal year.

Competitors to Watch: Stryker Corporation (NYSE:SYK), Bovie Medical Corporation (AMEX:BVX), Synovis Life Tech., Inc. (NASDAQ:SYNO), CryoLife, Inc. (NYSE:CRY), Medtronic, Inc. (NYSE:MDT), Smith & Nephew plc (NYSE:SNN), Vision-Sciences, Inc. (NASDAQ:VSCI), CONMED Corporation (NASDAQ:CNMD), The Cooper Companies, Inc. (NYSE:COO).

Stock Price Performance: During August 16, 2011 to October 12, 2011, the stock price had risen $33.16 (9.5%) from $349 to $382.16. The stock price saw one of its best stretches over the last year between June 24, 2011 and July 5, 2011 when shares rose for seven-straight days, rising 9.8% (+$33.97) over that span. It saw one of its worst periods between December 20, 2010 and December 30, 2010 when shares fell for eight-straight days, falling 5% (-$13.59) over that span. Shares are up $124.41 (+48.3%) year to date.

(Source: Xignite Financials)

Investing Insights: has a Stock Chart Technical Analysts Dream About.